{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T15:00:47Z","timestamp":1777561247706,"version":"3.51.4"},"reference-count":29,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2014,11,1]],"date-time":"2014-11-01T00:00:00Z","timestamp":1414800000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2014,11,1]],"date-time":"2014-11-01T00:00:00Z","timestamp":1414800000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["atherosclerosis-journal.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Atherosclerosis"],"published-print":{"date-parts":[[2014,11]]},"DOI":"10.1016\/j.atherosclerosis.2014.09.014","type":"journal-article","created":{"date-parts":[[2014,9,28]],"date-time":"2014-09-28T12:06:37Z","timestamp":1411905997000},"page":"259-263","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":18,"title":["Serum concentrations of galectin-3 in patients with cardiac syndrome X"],"prefix":"10.1016","volume":"237","author":[{"given":"Evin","family":"Bozcali","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Veli","family":"Polat","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gonul","family":"Aciksari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6335-5250","authenticated-orcid":false,"given":"Selcuk","family":"Opan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"\u0130brahim Halil","family":"Bayrak","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nurcan","family":"Paker","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Osman","family":"Karakaya","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.atherosclerosis.2014.09.014_bib1","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1016\/j.bbagen.2005.12.020","article-title":"Galectin-3: an open-ended story","volume":"1760","author":"Dumic","year":"2006","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.atherosclerosis.2014.09.014_bib2","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1161\/ATVBAHA.112.300569","article-title":"Galectin-3 mediates aldosterone-induced vascular fibrosis","volume":"33","author":"Calvier","year":"2013","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.atherosclerosis.2014.09.014_bib3","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1189\/jlb.69.4.555","article-title":"Expression and function of galectin-3, a \u03b2-galactoside-binding protein activated T lymphocytes","volume":"69","author":"Joo","year":"2001","journal-title":"J.\u00a0Leukoc. Biol."},{"key":"10.1016\/j.atherosclerosis.2014.09.014_bib4","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1006\/excr.1998.4253","article-title":"Galectin-3 stimulates cell proliferation","volume":"245","author":"Inohara","year":"1998","journal-title":"Exp. Cell Res."},{"key":"10.1016\/j.atherosclerosis.2014.09.014_bib5","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1093\/eurjhf\/hfp097","article-title":"Galectin-3: a novel mediator of heart failure development and progression","volume":"11","author":"De Boer","year":"2009","journal-title":"Eur. J. Heart Fail."},{"key":"10.1016\/j.atherosclerosis.2014.09.014_bib6","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1161\/ATVBAHA.107.159160","article-title":"Galectin-3 is an amplifier of inflammation in atherosclerotic plaque progression through macrophage activation and monocyte chemoattraction","volume":"28","author":"Papaspyridonos","year":"2008","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.atherosclerosis.2014.09.014_bib7","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1111\/j.1365-2796.2011.02476.x","article-title":"The fibrosis marker galectin-3 and outcome in the general population","volume":"272","author":"de Boer","year":"2012","journal-title":"J.\u00a0Intern. Med."},{"key":"10.1016\/j.atherosclerosis.2014.09.014_bib8","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.5551\/jat.12856","article-title":"Value and level of galectin-3 acute myocardial infarction patients undergoing primary percutaneous coronary intervention","volume":"19","author":"Tsai","year":"2012","journal-title":"J.\u00a0Atheroscler. Thromb."},{"key":"10.1016\/j.atherosclerosis.2014.09.014_bib9","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/S0002-9149(73)80150-X","article-title":"Left ventricular function in patients with anginal syndrome and normal coronary arteriograms","volume":"32","author":"Kemp","year":"1973","journal-title":"Am. J. Cardiol."},{"key":"10.1016\/j.atherosclerosis.2014.09.014_bib10","doi-asserted-by":"crossref","first-page":"1338","DOI":"10.1016\/0002-9149(88)91180-0","article-title":"\u201cMicrovascular angina\u201d as a cause of chest pain with angiographically normal coronary arteries","volume":"61","author":"Cannon","year":"1988","journal-title":"Am. J. Cardiol."},{"key":"10.1016\/j.atherosclerosis.2014.09.014_bib11","doi-asserted-by":"crossref","first-page":"1926","DOI":"10.1136\/hrt.2010.196626","article-title":"High prevalence of intramural coronary infection in patients with drug-resistant cardiac syndrome X: comparison with chronic stable angina and normal controls","volume":"96","author":"Chimenti","year":"2010","journal-title":"Heart"},{"key":"10.1016\/j.atherosclerosis.2014.09.014_bib12","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1097\/00019501-200202000-00004","article-title":"Cardiocytic apoptosis and capillary endothelial swelling as morphological evidence of myocardial ischemia in ventricular biopsies from patients with angina and normal coronary arteriograms","volume":"13","author":"Yamamoto","year":"2002","journal-title":"Coron. Artery Dis."},{"key":"10.1016\/j.atherosclerosis.2014.09.014_bib13","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1016\/j.jacc.2012.04.053","article-title":"Galectin-3, a marker of cardiac fibrosis, predicts incident heart failure in the community","volume":"60","author":"Ho","year":"2012","journal-title":"J.\u00a0Am. Coll. Cardiol."},{"key":"10.1016\/j.atherosclerosis.2014.09.014_bib14","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.1016\/j.jacc.2006.03.061","article-title":"Utility of amino-terminal pro-brain natriuretic peptide, galectin-3, and apelin for the evaluation of patients with acute heart failure","volume":"48","author":"Van Kimmenade","year":"2006","journal-title":"J.\u00a0Am. Coll. Cardiol."},{"key":"10.1016\/j.atherosclerosis.2014.09.014_bib15","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1007\/s00392-010-0125-y","article-title":"Prognostic value of galectin-3, a novel marker of fibrosis, in patients with chronic heart failure: data from the DEAL-HF study","volume":"99","author":"Lok","year":"2010","journal-title":"Clin. Res. Cardiol."},{"key":"10.1016\/j.atherosclerosis.2014.09.014_bib16","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1093\/eurjhf\/hfq091","article-title":"Galectin-3, cardiac structure and function, and long-term mortality in patients with acutely decompensated heart failure","volume":"12","author":"Shah","year":"2010","journal-title":"Eur. J. Heart Fail."},{"key":"10.1016\/j.atherosclerosis.2014.09.014_bib17","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1007\/s00392-012-0500-y","article-title":"Galectin-3 is an independent marker for ventricular remodeling and mortality in patients with chronic heart failure","volume":"102","author":"Lok","year":"2013","journal-title":"Clin. Res. Cardiol."},{"key":"10.1016\/j.atherosclerosis.2014.09.014_bib18","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1373\/clinchem.2011.174359","article-title":"Galectin-3 and the development of heart failure after acute coronary syndrome: pilot experience from PROVE IT-TIMI 22","volume":"58","author":"Grandin","year":"2012","journal-title":"Clin. Chem."},{"key":"10.1016\/j.atherosclerosis.2014.09.014_bib19","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1177\/039463201102400409","article-title":"Galectin-3 plasma levels and coronary artery disease: a new possible biomarker of acute coronary syndrome","volume":"24","author":"Falcone","year":"2011","journal-title":"Int. J. Immunopathol. Pharmacol."},{"key":"10.1016\/j.atherosclerosis.2014.09.014_bib20","doi-asserted-by":"crossref","DOI":"10.1093\/cvr\/cvt206","article-title":"The galectin-3\/RAGE dyad modulates vascular osteogenesis in atherosclerosis","author":"Menini","year":"2013","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.atherosclerosis.2014.09.014_bib21","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/S0014-5793(98)00683-8","article-title":"Galectin-3 gene (LGALS3) expression in experimental atherosclerosis and cultured smooth muscle cells","volume":"430","author":"Arar","year":"1998","journal-title":"FEBS Lett."},{"key":"10.1016\/j.atherosclerosis.2014.09.014_bib22","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1093\/glycob\/cwt006","article-title":"Inhibition of galectin-3 reduces atherosclerosis in apolipoprotein E-deficient mice","volume":"23","author":"MacKinnon","year":"2013","journal-title":"Glycobiology"},{"key":"10.1016\/j.atherosclerosis.2014.09.014_bib23","doi-asserted-by":"crossref","first-page":"2006","DOI":"10.1016\/j.ehj.2003.09.029","article-title":"Chronic inflammation and increased arterial stiffness in patients with cardiac syndrome X","volume":"24","author":"Arroyo-Espliguero","year":"2003","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.atherosclerosis.2014.09.014_bib24","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/j.cyto.2007.09.005","article-title":"Elevated circulating inflammatory markers in female patients with cardiac syndrome X","volume":"40","author":"Li","year":"2007","journal-title":"Cytokine"},{"key":"10.1016\/j.atherosclerosis.2014.09.014_bib25","doi-asserted-by":"crossref","first-page":"207","DOI":"10.2143\/AC.64.2.2036139","article-title":"Serum levels of C-reactive protein and uric acid in patients with cardiac syndrome X","volume":"64","author":"Eroglu","year":"2009","journal-title":"Acta Cardiol."},{"key":"10.1016\/j.atherosclerosis.2014.09.014_bib26","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1001\/archinternmed.2009.50","article-title":"Adverse cardiovascular outcomes in women with nonobstructive coronary artery disease: a report from the Women's Ischemia Syndrome Evaluation Study and the St James Women Take Heart Project","volume":"169","author":"Gulati","year":"2009","journal-title":"Arch. Intern. Med."},{"key":"10.1016\/j.atherosclerosis.2014.09.014_bib27","doi-asserted-by":"crossref","first-page":"2518","DOI":"10.1161\/01.CIR.0000128208.22378.E3","article-title":"Endothelial function predicts future development of coronary artery disease: a study of women with chest pain and normal coronary angiograms","volume":"109","author":"Bugiardini","year":"2004","journal-title":"Circulation"},{"key":"10.1016\/j.atherosclerosis.2014.09.014_bib28","doi-asserted-by":"crossref","first-page":"30","DOI":"10.14712\/fb2008054010030","article-title":"Inflammatory changes in small blood vessels in the endomyocardium of cardiac syndrome X in female patients with increased C-reactive protein","volume":"54","author":"Zorc-Pleskovic","year":"2008","journal-title":"Folia Biol."},{"key":"10.1016\/j.atherosclerosis.2014.09.014_bib29","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/0167-5273(94)90003-5","article-title":"Small vessel pathology and coronary hemodynamics in patients with microvascular angina","volume":"43","author":"Suzuki","year":"1994","journal-title":"Int. J. Cardiol."}],"container-title":["Atherosclerosis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021915014014166?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021915014014166?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,3]],"date-time":"2025-11-03T16:23:19Z","timestamp":1762186999000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0021915014014166"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,11]]},"references-count":29,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2014,11]]}},"alternative-id":["S0021915014014166"],"URL":"https:\/\/doi.org\/10.1016\/j.atherosclerosis.2014.09.014","relation":{},"ISSN":["0021-9150"],"issn-type":[{"value":"0021-9150","type":"print"}],"subject":[],"published":{"date-parts":[[2014,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Serum concentrations of galectin-3 in patients with cardiac syndrome X","name":"articletitle","label":"Article Title"},{"value":"Atherosclerosis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.atherosclerosis.2014.09.014","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier Ireland Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}